10-Q: Better Choice Company Reports Q3 2024 Results, Achieves Net Income Amidst Strategic Shifts

Better Choice Company Inc. reports a net income of $1.5 million for Q3 2024, a significant turnaround from a net loss in the same period last year, despite a decrease in net sales.

Summary

• Better Choice Company Inc. reported a net income of $1.5 million for the three months ended September 30, 2024, compared to a net loss of $1.6 million for the same period in 2023.
• Net sales for the quarter decreased by 13% to $11.4 million, down from $13.1 million in the prior year.
• The company's gross profit increased slightly to $4.5 million, with a gross margin of 40%, up from 34% in the same quarter of the previous year.
• Operating expenses decreased by 20% to $5.6 million, compared to $7.1 million in the prior year.
• For the nine months ended September 30, 2024, the company reported a net income of $1.3 million, a significant improvement from a net loss of $8.1 million in the same period of 2023.
• Net sales for the nine-month period decreased by 15% to $27.8 million, down from $32.9 million in the prior year.
• The company's gross profit for the nine-month period was $10.4 million, with a gross margin of 37%, up from 34% in the same period of the previous year.
• Operating expenses for the nine-month period decreased by 25% to $14.7 million, compared to $19.7 million in the prior year.
• The company has made strategic shifts, including exiting unprofitable customers in the Brick & Mortar channel and shutting down its direct-to-consumer (DTC) channel.
• A significant gain of $2.6 million was recognized from the extinguishment of debt and accounts payable related to the Alphia Term Loan settlement.

Sentiment

Score: 7

Explanation: The document shows a positive turnaround in profitability and strategic moves, but concerns remain about revenue decline and going concern issues. The sentiment is cautiously optimistic.

Positives

• The company achieved net income in both the third quarter and the nine-month period ending September 30, 2024, a significant turnaround from previous losses.
• Gross margins improved significantly, indicating better cost management and pricing strategies.
• Operating expenses were reduced, contributing to improved profitability.
• The extinguishment of the Alphia Term Loan resulted in a substantial gain, positively impacting the bottom line.
• The company successfully raised capital through a public offering.
• The acquisition of Aimia Pet Healthco expands the company's product portfolio into the pet obesity market.
• The proposed acquisition of SRx Health Solutions Inc. could significantly expand the company's reach into the healthcare sector.

Negatives

• Net sales decreased by 13% in Q3 2024 and 15% for the nine months ended September 30, 2024, indicating a decline in revenue.
• The company exited unprofitable customers in the Brick & Mortar channel, which contributed to the decrease in sales.
• The shutdown of the DTC channel also contributed to the decrease in sales.
• The company has a history of losses and expects to continue to generate operating losses and consume cash resources in the near term.
• The company's ability to continue as a going concern is in doubt, requiring additional capital or financing.
• The company is not in compliance with certain NYSE American listing standards.

Risks

• The company's ability to continue as a going concern is uncertain, requiring additional capital or financing.
• The company is subject to risks common in the pet wellness consumer market, including competition and dependence on key personnel.
• The company is not in compliance with certain NYSE American listing standards, which could lead to delisting.
• The company faces risks related to supply chain management, compliance with regulations, and potential product recalls.
• The company's financial performance could be negatively impacted by inflationary pressures and geopolitical actions.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company is dependent on a few major suppliers and customers, creating concentration risk.

Future Outlook

The company is focused on driving growth through brand awareness, new product innovation, and expansion in key sales channels. They aim to improve profitability through cost management and strategic shifts. The company is also pursuing a business combination with SRx Health Solutions, Inc. to expand into the healthcare sector.

Management Comments

• The company is committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives.
• The company's mission is to become the most innovative premium pet food company in the world.
• The company believes that its broad portfolio of pet health and wellness products are well positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness.
• The company has adopted a laser focused, channel specific approach to growth that is driven by new product innovation.
• The company is focused on targeting Chinese pet owners with the highest willingness to pay, which tend to be urban dwelling millennial and Gen-Z women.
• The company is implementing plans to achieve operating profitability, including various margin improvement initiatives, the consolidation of and introduction of new co-manufacturers, the optimization of pricing strategy and ingredient profiles, and new product innovation.

Industry Context

The pet food market is experiencing growth due to increased pet ownership and a focus on premium products. The company's strategic shifts, including exiting unprofitable channels and focusing on online sales, align with industry trends. The proposed acquisition of SRx Health Solutions Inc. represents a diversification strategy into the broader health and wellness market.

Comparison to Industry Standards

• The company's gross margin of 40% in Q3 2024 is competitive with other premium pet food brands, though specific benchmarks vary widely across the industry.
• The company's focus on online sales channels aligns with the trend of increasing e-commerce penetration in the pet food market, similar to companies like Chewy and Amazon.
• The company's strategic exit from certain brick-and-mortar retailers mirrors the challenges faced by many brands in balancing online and offline distribution.
• The company's move to acquire SRx Health Solutions Inc. is a unique strategy, not commonly seen in the pet food industry, indicating a potential shift towards a broader health and wellness focus.
• The company's financial performance, while showing improvement, still lags behind larger, more established players in the pet food industry, such as Nestle Purina and Mars Petcare, which have significantly higher revenue and profitability.

Management Changes

Corporate Governance

Legal Proceedings

• The company initiated a legal action to enforce a right of first refusal option exercised by Alphia, Inc. on March 25, 2024.
• The company agreed to settlement terms of the lawsuit with Alphia, Inc. on June 20, 2024, resulting in the forgiveness of the company's term loan and accounts payable.

Related Party Transactions

• The company pays quarterly board of director fees.
• The company had a marketing support services agreement with Believeco, a related party, which ended in 2024.

Stakeholder Impact

• Shareholders may be impacted by the company's stock repurchase plan and the potential for delisting from the NYSE American.
• Employees may be impacted by changes in management and potential restructuring efforts.
• Customers may be impacted by changes in the company's sales channels and product offerings.
• Suppliers may be impacted by changes in the company's purchasing patterns and supply chain management.
• Creditors may be impacted by the company's debt obligations and ability to continue as a going concern.

Next Steps

• The company will continue to implement plans to achieve operating profitability.
• The company will focus on brand awareness, new product innovation, and expansion in key sales channels.
• The company will work to regain compliance with NYSE American listing standards.
• The company will seek to complete the acquisition of SRx Health Solutions Inc.
• The company will continue to evaluate the market for the Common Stock and make a determination regarding additional repurchases prior to December 31, 2024.

Key Dates

Keywords

pet food, pet health, wellness, net income, gross margin, operating expenses, debt extinguishment, public offering, acquisition, SRx Health, Halo brand, DTC, e-commerce, international sales, financial results